The board (the "Board") of directors Zylox-Tonbridge Medical Technology Co., Ltd. announced that Mr. Hongze Liang ("Mr. Liang") has indicated he will not offer himself for re-election as an independent non-executive Director at the upcoming annual general meeting of the Company (the "AGM") due to other work commitments. Accordingly, Mr. Liang will cease to be an independent non-executive Director and a member of each of the audit committee (the "Audit Committee") and the remuneration committee (the "Remuneration Committee") of the Company upon conclusion of the AGM.
Zylox-Tonbridge Medical Technology Co., Ltd.
Equities
2190
CNE100004JD2
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.32 HKD | +0.71% | +2.54% | -9.00% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.00% | 469M | |
+16.65% | 133B | |
-3.76% | 11.52B | |
-4.86% | 8.3B | |
+43.30% | 5.73B | |
-22.44% | 4.69B | |
+7.79% | 3.42B | |
-17.26% | 2.54B | |
-13.36% | 2.03B | |
-16.39% | 1.86B |
- Stock Market
- Equities
- 2190 Stock
- News Zylox-Tonbridge Medical Technology Co., Ltd.
- Zylox-Tonbridge Medical Technology Co., Ltd. Announces Retirement of Hongze Liang as an Independent Non-Executive Director